Rohto Pharmaceutical. (4527.TSE) Q3 2026 Earnings

12AugConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
26.12
33.64
41.16
48.69

Details

Expected EPS
48.68847073375999
Actual EPS
N/A
Surprise EPS
-48.69
Surprise Percent
+100%

Description

Rohto Pharmaceutical. (4527.TSE) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts